Intrapleural Tissue Plasminogen Activator and Dornase Alfa in Pediatric Empyema

This randomized clinical trial investigates if intrapleural tissue plasminogen activator and dornase alfa is more effective than intrapleural tissue plasminogen activator alone at reducing hospital length of stay in children with pleural empyema.
Source: JAMA Pediatrics - Category: Pediatrics Source Type: research